Additional file 1: Fig. S1. CTGF enhance the growth of AEC2s in vitro. (A) High-magnification images of the RNAscope staining of Sftpc, AQP5 and Ki67 of the AEC2s organoids. Scale bar, 50 μm. (B) High-magnification images of the immunofluorescence staining of Sftpc and T1a of the AEC2s organoids. Scale bar, 50 μ
Figure S6. Histopathological findings in the lung (A, B), liver (C, D), and spleen (E, F) sections s...
Table S4. Patient data. Spreadsheet containing patient characteristics (gender, age at diagnosis, CO...
Additional file 1: Supplemetary methods and Figure S1. Characteristics of MSCs; Figure S2. Quality c...
Additional file 4: Fig. S4. RNAscope analysis of Krt5: expressing AEC2s and Axin2+ AEC2s. High-magni...
Additional file 4: Fig. S4. RNAscope analysis of Krt5: expressing AEC2s and Axin2+ AEC2s. High-magni...
Additional file 3: Fig. S3. RNA-seq analysis of Krt5 expressing AEC2s and Krt5− AEC2s: Krt5 expressi...
Additional file 2: Fig. S2. Dose effect of CTGF and mouse pulmonary fibrosis. (A) Masson staining wa...
Additional file 6: Data file S1. The results of protein mass spectrometry of lung tissue post LPS-in...
Additional file 5: Table S1. Overall clinical characteristics of patients with ARD
Relative intensity of each band on the representative image of western blot. The relative intensity ...
Table S1. Results from 1Â W-ANOVA for regulation between experimental groups. Spreadsheet containing...
Additional file 1: Figure S1. The identification of EPCs. Representative images of immunofluorescenc...
Supplementary data. Table S1. Primer Sequences of various genes. Table S2. CSC-induced mRNA expressi...
Detailed description of procedures for fixation, sampling and embedding and Detailed description of ...
Survival rate in untreated CLP animals and those treated with cells. Survival rate at days 1 and 3 a...
Figure S6. Histopathological findings in the lung (A, B), liver (C, D), and spleen (E, F) sections s...
Table S4. Patient data. Spreadsheet containing patient characteristics (gender, age at diagnosis, CO...
Additional file 1: Supplemetary methods and Figure S1. Characteristics of MSCs; Figure S2. Quality c...
Additional file 4: Fig. S4. RNAscope analysis of Krt5: expressing AEC2s and Axin2+ AEC2s. High-magni...
Additional file 4: Fig. S4. RNAscope analysis of Krt5: expressing AEC2s and Axin2+ AEC2s. High-magni...
Additional file 3: Fig. S3. RNA-seq analysis of Krt5 expressing AEC2s and Krt5− AEC2s: Krt5 expressi...
Additional file 2: Fig. S2. Dose effect of CTGF and mouse pulmonary fibrosis. (A) Masson staining wa...
Additional file 6: Data file S1. The results of protein mass spectrometry of lung tissue post LPS-in...
Additional file 5: Table S1. Overall clinical characteristics of patients with ARD
Relative intensity of each band on the representative image of western blot. The relative intensity ...
Table S1. Results from 1Â W-ANOVA for regulation between experimental groups. Spreadsheet containing...
Additional file 1: Figure S1. The identification of EPCs. Representative images of immunofluorescenc...
Supplementary data. Table S1. Primer Sequences of various genes. Table S2. CSC-induced mRNA expressi...
Detailed description of procedures for fixation, sampling and embedding and Detailed description of ...
Survival rate in untreated CLP animals and those treated with cells. Survival rate at days 1 and 3 a...
Figure S6. Histopathological findings in the lung (A, B), liver (C, D), and spleen (E, F) sections s...
Table S4. Patient data. Spreadsheet containing patient characteristics (gender, age at diagnosis, CO...
Additional file 1: Supplemetary methods and Figure S1. Characteristics of MSCs; Figure S2. Quality c...